5 research outputs found
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-69784 1 Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
N.B.: When citing this work, cite the original article
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-68122 Prognostic utility of HOXB13:IL17BR and Molecular Grade Index in early stage breast cancer patients from the Stockholm trial Running title: Prognostic Utility of the Breast Cancer Index
Background A dichotomous index combining two gene expression assays, HOXB13:IL17BR (H:I) and molecular grade index (MGI), was developed to asses
Open Access
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trial